The FDA announced on Jan. 21, 2025, that Major Pharmaceuticals is recalling Lorazepam Tablets, USP, 0.5mg due to failed impurity specifications and sub-potent drug results. The agency stated the recall is voluntary and ongoing.
How to tell if you have it
- Brand: Major Pharmaceuticals
- Product: Lorazepam Tablets, USP, 0.5mg, Unit Dose
- Packaging: 100 tablets per carton (10 x 10 blister packs)
- NDC: 0904-6007-61
- Lot codes: N01424, N01425, N01659, N01660, N01668, N01679, N01704, N01745, N01856, N01973, N02079
- Expiration dates: 03/31/2025, 08/31/2025, 09/2025, 10/31/2025, 02/28/2026, 05/31/2026, 08/31/2026
- Quantity: 82,281 cartons
- Distribution: Nationwide U.S. and Puerto Rico
The hazard
According to the FDA, out-of-specification results were obtained during routine stability testing for Assay and Impurities. The drug product contained failed impurities/degradation specifications and was sub-potent.
Context
GovInfoNow's records show that Major Pharmaceuticals has had 14 other recalls on record since May 31, 2023. Other recent recalls of similar products include Major Chlorpromazine 50mg Tablets Recall (Sept. 12, 2025), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (Sept. 2, 2025), and Major Pharmaceuticals Carvedilol Tablets Recall (Aug. 20, 2025). Other recent recalls of similar products include Ajanta Pharma Fluphenazine Tablets Recall (Aug. 25, 2026), Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), and Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026).